EWTX
Edgewise Therapeutics, Inc.
$45.93+0.11 (+0.24%)Close Nov 13, 2026
Mar 26, 2021 – Nov 13, 2026, Dividends reinvested
- Final balance
- $15,310
- CAGR
- +7.85%
- Max drawdown
- −84.69%
- Sharpe ratio
- 0.48
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
EWTX's average annual return was 19.05% over the last 5 years, through Nov 13, 2026. $10,000 in EWTX on Nov 12, 2021 grew to $23,909 by Nov 13, 2026, with dividends reinvested.
Total
- 1M
- +26.60%
- 3M
- +6.37%
- 6M
- +36.05%
- YTD
- +85.09%
- 1Y
- +124.93%
Per year
- 3Y
- +95.68%
- 5Y
- +19.05%
- Since 2021
- +7.85%
Annual returns
2021 from Mar 26 · 2026 through Nov 13
EWTX returns by year
| Year | Return |
|---|---|
| 2026 through Nov 13 | +85.09% |
| 2025 | −7.06% |
| 2024 | +144.06% |
| 2023 | +22.37% |
| 2022 | −41.49% |
| 2021 from Mar 26 | −49.07% |
Metrics
Since 2021| Volatility | 79.86% |
|---|---|
| Sortino ratio | 0.78 |
| Calmar ratio | 0.09 |
| Best year, 2024 | +144.06% |
| Worst year, 2022 | −41.49% |
| Positive years | 2 of 4 |
| Longest drawdown | 3.6 years |
Worst drawdowns
Since 2021| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −84.7% | Mar 2021 | Nov 2023 | Nov 2024 | 3.6 years |
| −68.8% | Nov 2024 | Apr 2025 | May 2026 | 1.5 years |
| −25.0% | Jul 2026 | Oct 2026 | Nov 2026 | 4 months |
| −18.2% | Jun 2026 | Jun 2026 | Jun 2026 | 3 weeks |
| −17.3% | May 2026 | May 2026 | Jun 2026 | 4 weeks |